Diurnal Group PLC Correction: Director Dealings (4562Y)
May 13 2021 - 1:00AM
UK Regulatory
TIDMDNL
RNS Number : 4562Y
Diurnal Group PLC
13 May 2021
13 May 2021
Diurnal Group plc
("Diurnal" or the "Company")
Correction: Director Dealings
This is a correction to the Director Dealings announcement
published at 3:44 p.m. on 12 May 2021 (RNS number 4297Y) which has
been amended with the correct total beneficial interests of Sam
Williams, Interim Chairman and Richard Bungay, Chief Financial
Officer each of 0.07% of the total voting rights.
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical
company targeting patient needs in chronic endocrine (hormonal)
diseases, announces that further to the Capital Raising, details of
which were announced on 21 April 2021 and Admission, the following
Directors' dealings as part of the Subscription and Open Offer have
completed:
Sam Williams, Interim Chairman, subscribed for 28,571 Ordinary
Shares at a price of 70 pence per Ordinary Share.
Martin Whitaker, Chief Executive Officer, subscribed for a total
of 10,000 Ordinary Shares at 70 pence per share, including 6,000
shares to be held in pension schemes for the beneficial interest of
his dependent children.
Richard Bungay, Chief Financial Officer, subscribed for 7,143
Ordinary Shares at a price of 70 pence per Ordinary Share.
John Goddard, Non-Executive Director, subscribed for 28,571
Ordinary Shares at a price of 70 pence per Ordinary Share.
Following Admission, the total beneficial interest of Sam
Williams is 113,819 Ordinary Shares, representing 0.07% of the
total voting rights, Martin Whitaker and his connected parties is
603,823 Ordinary Shares, representing 0.36% of the total voting
rights, the total beneficial interest of Richard Bungay is 114,252
Ordinary Shares, representing 0.07% of the total voting rights and
the total beneficial interest of John Goddard is 228,674 Ordinary
Shares, representing 0.14% of the total voting rights.
The capitalised terms used in this announcement have the same
meanings as in the announcement published by the Company at 7.00
a.m. on 21 April 2021 unless otherwise stated.
Details of the full notifications received by the Company are
set out below:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Names Sam Williams
Martin Whitaker and dependent children
Richard Bungay
John Goddard
--------------------------------------- ---------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------
a) Position/status Interim Chairman
Chief Executive Officer
Chief Financial Officer
Non-Executive Director
--------------------------------------- ---------------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- ---------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name Diurnal Group plc
--------------------------------------- ---------------------------------------------
b) LEI 213800I2HNUNZN1LDH29
--------------------------------------- ---------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Purchase of Ordinary Shares
--------------------------------------- ---------------------------------------------
c) Price(s) and volume(s)
-------------------- --------------------
Price(s) Volume(s)
-------------------- --------------------
70p 28,571
-------------------- --------------------
70p 10,000
-------------------- --------------------
70p 7,143
-------------------- --------------------
70p 28,571
-------------------- --------------------
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 11 May 2021
--------------------------------------- ---------------------------------------------
f) Place of the transaction XLON
--------------------------------------- ---------------------------------------------
For further information, please visit www.diurnal.co.uk or
contact:
+44 (0)20 3727
Diurnal Group plc 1000
Martin Whitaker, Chief Executive Officer
Richard Bungay, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser +44 (0)20 7886
and Sole Broker) 2500
Corporate Finance: Freddy Crossley, Emma Earl
Corporate Broking: Rupert Dearden
+44 (0)20 3727
FTI Consulting (Media and Investor Relations) 1000
Simon Conway
Victoria Foster Mitchell
Alex Davis
Notes to Editors
About Diurnal Group plc
Diurnal Group plc is a European, UK-headquartered, specialty
pharmaceutical company dedicated to developing hormone therapeutics
to aid lifelong treatment for rare and chronic endocrine
conditions, including congenital adrenal hyperplasia, adrenal
insufficiency, hypogonadism and hypothyroidism. Its expertise and
innovative research activities focus on circadian-based
endocrinology to yield novel product candidates in the rare and
chronic endocrine disease arena.
For further information about Diurnal, please visit
www.diurnal.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBCGDUXDBDGBD
(END) Dow Jones Newswires
May 13, 2021 02:00 ET (06:00 GMT)
Diurnal (LSE:DNL)
Historical Stock Chart
From Apr 2024 to May 2024
Diurnal (LSE:DNL)
Historical Stock Chart
From May 2023 to May 2024